Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda

Annals of Clinical Microbiology and Antimicrobials

Volumn 6, Issue , 2007, Pages

  Traore, Hamidou ^a   Ogwang, Sam ^b   Mallard, Kim ^a   Joloba, Moses L ^c   Mumbowa, Francis ^b   Narayan, Kalpana ^a,d   Kayes, Susan ^b   Jones Lopez, Edward C ^d   Smith, Peter G ^a   Ellner, Jerrold J ^d   Mugerwa, Roy D ^c   Eisenach, Kathleen D ^e   McNerney, Ruth ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^c MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FALSE NEGATIVE RESULT; GENE MUTATION; GENETIC CODE; INTERMETHOD COMPARISON; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; UGANDA;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 33846854673     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-6-1     Document Type: Article

References (18)

1. World Health Organisation Anti-tuberculosis drug resistance in the world: Report Number 3. The WHO/IUALTD global project on anti-tuberculosis drug resistance surveillance. WHO/CDS/TB/2004343 Geneva, WHO 2004
2. Morgan M Kalantri S Flores L Pai M A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis BMC Infect Dis 2005 5 62 1185540 16050959
3. Traore H Fissette K Bastian I Devleeschouwer M Portaels F Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance Int J Tuberc Lung Dis 2000 4 5 481-484 10815743
4. Wilson SM al-Suwaidi Z McNerney R Porter J Drobniewski F Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis Nat Med 1997 3 4 465-468 9095184
5. Jones WD David HL Inhibition by rifampin of mycobacteriophage D29 replication in its drug-resistant host, Mycobacterium smegmatis ATCC 607. Am Rev Respir Dis 1971 103 618-624 5579905
6. McNerney R Kiepiela P Bishop KS Nye PM Stoker NG Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin Int J Tuberc Lung Dis 2000 4 1 69-75 10654647
7. Telenti A Imboden P Marchesi F Lowrie D Cole S Colston MJ Matter L Schopfer K Bodmer T Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis Lancet 1993 341 8846 647-650 8095569
8. McNerney R Micro-well phage replication assay for screening mycobacteria for resistance to rifampicin and streptomycin Antibiotic Resistance Methods and Protocols Towota, NY, Humana Press Inc Gillespie SH Methods in Molecular Medicine Walker MJ 2001 48 21-30
9. Siddiqi SH BACTEC 460 TB System. Product and Procedure Manual Sparks, MD, Becton Dickinson Diagnostic Instrument Systems 1995
10. van Embden JD Cave MD Crawford JT Dale JW Eisenach KD Gicquel B Hermans P Martin C McAdam R Shinnick TM Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology J Clin Microbiol 1993 31 2 406-409 262774 8381814
11. Ohno H Koga H Kuroita T Tomono K Ogawa K Yanagihara K Yamamoto Y Miyamoto J Tashiro T Kohno S Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis Am J Respir Crit Care Med 1997 155 6 2057-2063 9196115
12. Abate G Mshana RN Miorner H Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis Int J Tuberc Lung Dis 1998 2 12 1011-1016 9869118
13. Gali N Dominguez J Blanco S Prat C Quesada MD Matas L Ausina V Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates J Clin Microbiol 2003 41 6 2647-2649 156511 12791894
14. Albert H Trollip AP Mole RJ Hatch SJ Blumberg L Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test Int J Tuberc Lung Dis 2002 6 6 523-528 12068986
15. Mani C Selvakumar N Kumar V Narayanan S Narayanan PR Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis Int J Tuberc Lung Dis 2003 7 7 652-659 12870686
16. Simboli N Takiff H McNerney R Lopez B Martin A Palomino JC Barrera L Ritacco V In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings Antimicrob Agents Chemother 2005 49 1 425-427 538913 15616326
17. Yzquierdo SL Lemus D Echemendia M Montoro E McNerney R Martin A Palomino JC Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis Ann Clin Microbiol Antimicrob 2006 5 11 1481552 16630356
18. Heep M Brandstatter B Rieger U Lehn N Richter E Rusch-Gerdes S Niemann S Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates J Clin Microbiol 2001 39 1 107-110 87688 11136757